SSY Group's book value per share for the quarter that ended in Jun. 2024 was HK$2.45.
During the past 12 months, SSY Group's average Book Value Per Share Growth Rate was 14.40% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 8.00% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 10.10% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 10.80% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of SSY Group was 36.90% per year. The lowest was -1.30% per year. And the median was 11.90% per year.
SSY Group's current price is HK$3.52. Its book value per share for the quarter that ended in Jun. 2024 was HK$2.45. Hence, today's PB Ratio of SSY Group is 1.51.
During the past 13 years, the highest P/B Ratio of SSY Group was 7.70. The lowest was 1.43. And the median was 2.79.
Good Sign:
SSY Group Ltd stock PB Ratio (=1.44) is close to 10-year low of 1.43
SSY Group Book Value per Share Historical Data
The historical data trend for SSY Group's Book Value per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of SSY Group's Book Value per Share
For the Drug Manufacturers - Specialty & Generic subindustry, SSY Group's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SSY Group's PB Ratio Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, SSY Group's PB Ratio distribution charts can be found below:
* The bar in red indicates where SSY Group's PB Ratio falls into.
SSY Group Book Value per Share Calculation
SSY Group's Book Value Per Share for the fiscal year that ended in Dec. 2023 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.
SSY Group (HKSE:02005) Book Value per Share Explanation
Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.
For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.
SSY Group Book Value per Share Related Terms
Thank you for viewing the detailed overview of SSY Group's Book Value per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
SSY Group Ltd is engaged in the research, development, manufacturing and selling of a wide range of pharmaceutical products, which includes finished medicines of mainly intravenous infusion solution and ampoule injection to hospitals and distributors, bulk pharmaceuticals and medical materials. The company has two reportable segments including intravenous infusion solution and others and medical materials. The company derives a vast majority of its revenue principally from the Intravenous infusion solution and others. Revenue generation is driven mostly by its sales of pharmaceutical products, followed by medical materials.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:02005 has been successfully added to your 